Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Sustained Effects of Ketamine
NCT02708849Phase 1Terminated
- Sponsor
- Yale University
- Start
- Jun 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing Ketamine + Lamotrigine with Ketamine + Placebo (2 arms). Primary endpoint: Global Brain Connectivity at 24 hours. Started Jun 2015; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02708849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02708849.